1056PDPhase I experience with rogaratinib in patients with head and neck cancer selected based on FGFR mRNA overexpression
Joerger, M, Takahashi, S, Sayehli, C M, Slosarczyk, S, Navarro Mendivil, A, Cassier, P A, Nogai, H, Zhang, C, Sei, F, Bender, S, Ellinghaus, P, Tahara, MVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy287.012
Date:
October, 2018
File:
PDF, 80 KB
2018